Masataka SUWA

Dr. Masataka SUWA

Department of Food and Nutrition, Koriyama Women's University
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2003 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
Masataka SUWAMasataka SUWA
Masataka SUWA
HNHiroshi Nakano
Hiroshi Nakano
SKShuzo Kumagai
Shuzo Kumagai
This study was designed to determine the histological and metabolic effects of the administration of 5′-AMP-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) for 14 successive days. AICAR treatment caused a significant decrease in the percentage of type IIB fibers and the concomitant increase in the percentage of type IIX fibers in extensor digitorum longus (EDL) muscle. The capillary density and the capillary-to-fiber ratio were not altered by AICAR. AICAR treatment increased the glycolytic and oxidative enzyme activities but not the antioxidant enzyme activities. The AICAR treatment increased the uncoupling protein 3 (UCP3) level in EDL and the peroxisome proliferator-activated receptor-γ coactivator-1α protein level in the soleus and EDL muscles, whereas the myogenin level was not altered by AICAR. These results seem to imply that the chronic activation of AMPK alters such muscle histochemical and metabolic characteristics.

1 December 2006 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
Masataka SUWAMasataka SUWA
Masataka SUWA
TEToru Egashira
Toru Egashira
HNHiroshi Nakano
Hiroshi Nakano
HSHaruka Sasaki
Haruka Sasaki
SKShuzo Kumagai
Shuzo Kumagai
AMP-activated protein kinase (AMPK), which was activated by an antihyperglycemic drug metformin, has been hypothesized to mediate metabolic adaptations. The purposes of the present study were 1) to confirm whether acute metformin administration induced AMPK phosphorylation and 2) to determine whether chronic metformin treatment increased the peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) protein expression, glycolytic and oxidative enzyme activities, and cytochrome c and glucose transporter-4 (GLUT4) protein expressions in the rat soleus and red and white gastrocnemius muscles. The single oral administration of metformin (300 mg/kg body wt) enhanced the AMPK phosphorylation at 5 and/or 6 h after treatment. In the chronic study, rats were fed either normal chow or chow containing 1% metformin for 14 days. Metformin treatment resulted in a mean daily metformin intake of 631 mg·kg body wt−1·day−1. Metformin increased the PGC-1α content in all three muscles. Metformin increased the hexokinase activity in the white gastrocnemius, the citrate synthase activity in all three muscles, and the β-hydroxyacyl-CoA dehydrogenase activity in the soleus. The cytochrome c protein content in the soleus muscle also increased. The GLUT4 content was unchanged by metformin. These results suggest that metformin enhances the PGC-1α expression and mitochondrial biogenesis possibly at least in part via AMPK phosphorylation in the skeletal muscle. Metformin has thus been proposed to possibly ameliorate insulin resistance, at least partially, by means of such metabolic effects.

1 July 2006 in Metabolism
Verified
Journal Article
Closed access
Masataka SUWAMasataka SUWA
Masataka SUWA
HKHiroyo Kishimoto
Hiroyo Kishimoto
YNYu Nofuji
Yu Nofuji
HNHiroshi Nakano
Hiroshi Nakano
HSHaruka Sasaki
Haruka Sasaki
SKShuzo Kumagai
Shuzo Kumagai

1 July 2008 in Metabolism
Verified
Journal Article
Closed access
Masataka SUWAMasataka SUWA
Masataka SUWA
HNHiroshi Nakano
Hiroshi Nakano
Zsolt RadakZsolt Radak
Zsolt Radak
SKShuzo Kumagai
Shuzo Kumagai

1 May 2008 in Neuroscience Letters
Verified
Journal Article
Closed access
YNYu Nofuji
Yu Nofuji
Masataka SUWAMasataka SUWA
Masataka SUWA
YMYoshihiko Moriyama
Yoshihiko Moriyama
HNHiroshi Nakano
Hiroshi Nakano
AIAtsushi Ichimiya
Atsushi Ichimiya
SKShuzo Kumagai
Shuzo Kumagai

HSHideki SHIMAMOTO
Hideki SHIMAMOTO
Masataka SUWAMasataka SUWA
Masataka SUWA
KMKoh Mizuno
Koh Mizuno
In Japan and other developed countries, the lifestyles of many—particularly the younger generation—have been disrupted in recent years. This disruption may manifest as a decrease in physical activity and deterioration in the quality and quantity of sleep. Depressive tendencies are also increasing among university students. This study examined the relationship between mental health, physical activity, physical fitness, and daytime sleepiness. Eighty-five undergraduate students participated in this study (52 men and 33 women, aged 18.9 (±1.4) years). Physical activity levels were measured using an accelerometer (Lifecorder, Kenz, Nagoya, Japan) for two weeks. To evaluate their level of physical fitness, maximal oxygen uptake (V˙O2max) was calculated by an indirect method using a cycle ergometer. Depressive tendencies and daytime sleepiness were evaluated using the Patient Health Questionnaire (PHQ-9). The PHQ-9 score was positively correlated with sleepiness (r = 0.35, p = 0.001) and total steps per day (r = 0.39, p < 0.001). Moreover, the PHQ-9 score was positively correlated with V˙O2max (r = 0.25, p = 0.019). The PHQ-9 score was higher in students with good exercise habits or part-time jobs. An important finding was the positive correlation between depression and variables related to physical activity levels. These results suggest that vigorous physical activity, such as exercise and part-time jobs, might be positively associated with depressive tendencies among university students.